[Agonists and antagonists of the platelet activating factor (PAF). II]. 1990

M Nechifor
Catedra de farmacologie, Institutul de Medicină şi Farmacie, Iaşi.

UI MeSH Term Description Entries
D010972 Platelet Activating Factor A phospholipid derivative formed by PLATELETS; BASOPHILS; NEUTROPHILS; MONOCYTES; and MACROPHAGES. It is a potent platelet aggregating agent and inducer of systemic anaphylactic symptoms, including HYPOTENSION; THROMBOCYTOPENIA; NEUTROPENIA; and BRONCHOCONSTRICTION. AGEPC,Acetyl Glyceryl Ether Phosphorylcholine,PAF-Acether,Phosphorylcholine, Acetyl Glyceryl Ether,1-Alkyl-2-acetyl-sn-glycerophosphocholine,Platelet Aggregating Factor,Platelet Aggregation Enhancing Factor,Platelet-Activating Substance,Thrombocyte Aggregating Activity,1 Alkyl 2 acetyl sn glycerophosphocholine,Aggregating Factor, Platelet,Factor, Platelet Activating,PAF Acether,Platelet Activating Substance
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Nechifor
February 1991, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
M Nechifor
January 1990, Critical reviews in therapeutic drug carrier systems,
M Nechifor
January 1987, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
M Nechifor
December 2007, Bioorganic & medicinal chemistry letters,
M Nechifor
January 1991, Advances in prostaglandin, thromboxane, and leukotriene research,
M Nechifor
January 1995, Sheng li ke xue jin zhan [Progress in physiology],
M Nechifor
December 1982, Agents and actions,
M Nechifor
January 1989, Advances in prostaglandin, thromboxane, and leukotriene research,
Copied contents to your clipboard!